Highlights and Quick Summary
- Net Profit Margin for the quarter ending March 31, 2023 was -8142.59% (a -78.93% decrease compared to previous quarter)
- Year-over-year quarterly Net Profit Margin decreased by -Infinity%
- Annual Net Profit Margin for 2022 was -24942.47% (a -0.0% decrease from previous year)
- Annual Net Profit Margin for 2022 was -24942.47% (a 6.01% increase from previous year)
- Annual Net Profit Margin for 2021 was -23528.81% (a -0.0% decrease from previous year)
- Twelve month Net Profit Margin ending March 31, 2023 was -17213.79% (a -20.53% decrease compared to previous quarter)
- Twelve month trailing Net Profit Margin decreased by -29.1% year-over-year
Trailing Net Profit Margin for the last four month:
| 31 Mar '23 | 31 Dec '22 | 30 Sep '22 | 30 Jun '22 |
|---|---|---|---|
| -17213.79% | -21662.07% | 0.0% | -24277.33% |
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Profit Margin of Benitec Biopharma Limited
Most recent Net Profit Marginof BNTC including historical data for past 10 years.Interactive Chart of Net Profit Margin of Benitec Biopharma Limited
Benitec Biopharma Limited Net Profit Margin for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | -8142.59% | – | – | – | – |
| 2022 | -38650.0% | 0.0% | 0.0% | -6822.92% | -24942.47% |
| 2021 | -19284.0% | 0.0% | -200150.0% | -390900.0% | -23528.81% |
| 2020 | -325200.0% | -4941.82% | 8152.78% | -7507.14% | -8111.76% |
| 2019 | – | – | -2714.29% | -3475.76% | 21.39% |
| 2018 | – | – | – | – | -247.29% |
| 2017 | – | – | – | -327.66% | -51.29% |
| 2016 | – | – | – | 12.81% | -611.21% |
| 2015 | – | – | – | – | -289.75% |
| 2014 | – | – | – | – | -512.41% |
| 2013 | – | – | – | – | -238.21% |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology